LCLNLincoln International, Inc.

🇺🇸 US
24.55
USD
Analysis Scores
Lothien Robustness Score?
-
Neden bu skor?
Damodaran ?
-
Dalio Risk ?
-
Piotroski ?
N/A
Yetersiz çeyrek verisi: 4 mevcut, en az 5 gerekli
Graham ?
$11.3
Pahalı
Lothien Robustness Summary
73/100
Lothien Sağlamlık: Güçlü (73/100)
Genel tablo olumlu. Finansal yapı sağlam, bazı riskler mevcut. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 8 | Negatif: 3 | Nötr: 2
Net Kâr Pozitif
Son çeyrekte $10M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Artışı
Net kâr bir önceki çeyreğe göre %+2083.5 arttı ($455,000 → $10M). Kısa vadede olumlu momentum.
Yıllık Kâr Geriledi
Geçen yılın aynı dönemine göre net kâr %-80.4 düştü. Uzun vadede endişe verici.
4 Çeyrek Üst Üste Artış
Son 4 çeyrek üst üste kâr artıyor. Güçlü yukarı trend devam ediyor.
Hasılat Büyümesi Güçlü
Satış gelirleri çeyreklik %+30.1 arttı ($226M → $294M). Talep güçlü.
Yıllık Hasılat Büyümesi Güçlü
Yıllık hasılat %+57.3 arttı. Şirket büyüyor.
Net Nakit Pozisyonu
Şirketin nakdi borçlarından $261M fazla. Borç riski düşük.
Borç Azalıyor
Toplam borç çeyreklik %-57.9 düştü. Bilanço güçleniyor.
Güçlü Nakit Üretimi
Serbest nakit akışı ($121M) kârın %1216'sini nakit olarak üretiyor. Kâr kalitesi yüksek.
Yüksek PD/DD
PD/DD: 6.36. Piyasa defter değerinin çok üstünde fiyatlıyor. Büyüme beklentisi primli.
Düşük ROE
ROE: %1.6. Sermaye getirisi yetersiz — enflasyonun altında.
Mevsimsel Toparlanma, Ama Trend Bozuk
Çeyreklik artış (%+2083.5) ama yıllık bazda düşüş (%-80.4). Mevsimsel toparlanma var ama uzun vadeli trend zayıf.
Sonraki Çeyrek: Düşüş Beklentisi
Tahminine göre kâr %-92.2 düşebilir. Sonraki bilançoya dikkat.

Data date date not measured Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date date not measured
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Valuation
Potential?
-
Balance Sheet Analysis? Q2026/9
Net kâr çeyreklik %+2083.5 artarak 9.9M USD oldu
Yıllık net kâr %-80.4 geriledi
Hasılat çeyreklik %+30.1 büyüdü (293.7M USD)
Yıllık hasılat büyümesi güçlü (%+57.3)
Net kâr marjı düşük: %3.4
Toplam borç %-57.9 azaldı → 101.9M USD
Net nakit pozisyonunda: -261.2M USD (borçsuz)
Borç/Özkaynak oranı: 0.68x
Nakit %+44.9 arttı → 363.1M USD
İşletme nakit akışı pozitif: 122.0M USD
Serbest nakit akışı pozitif: 120.8M USD
ROE düşük: %6.7
ROA düşük: %0.9
Toplam varlıklar %+13.3 büyüdü → 1.1B USD
Özkaynak %+10.6 arttı → 148.8M USD
İşletme kârı pozitif: 44.3M USD
İşletme kârı büyüme: %+378.8
CAPEX: 1.2M USD (Hasılatın %0.4'i)
Son 2 çeyrek ardışık kâr
Fiyat TRAMA-99 hafif altında: %+0.0
Direnç seviyesi: TRAMA-99 = 24.55 USD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %3.4
Net profit margin %3.4 — positive but low. Compared to previous quarter +3.2 point increase.
ROE - Return on Equity (TTM) %1.6
ROE %1.6 — low return on equity.
Free Cash Flow Margin (TTM) %35.6
TTM Free Cash Flow is %35.6'i. Strong FCF generation — profit quality is high.
Valuation
P/B Ratio 6.36x Sector: 3.47x
PD/DD 6.36x — sector median's %83 above. Expensive book value.
EV/EBITDA 11.9x Sector: 19.3x
EV/EBITDA 11.9x — sector median's (19.3x) %38 below. Cheap relative to EBITDA.
Indebtedness
Current Ratio 1.65x
Current ratio 1.65x — can comfortably cover short-term debts.
Net Debt / EBITDA 3.4x
Net Debt/EBITDA 3.4x — high debt burden. Debt service creating pressure.
Debt / Equity 1.80x
Debt/Equity 1.80x — high leverage. Sensitive to debt cycle changes.
Interest Coverage 6.4x
Interest coverage 6.4x — interest obligations comfortably covered.
Growth
Revenue Growth (YoY) %+57.3
Revenue YoY %57.3 grew (2026/9) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY) %-80.4
Net profit YoY %-80.4 declined (2026/9) — serious profit erosion.
Score Explanations
Lothien Robustness
-
Good robustness (64/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Potential
-
Plus %43.7 expected value (35.27) vs current price comparison. 3/4 valuation models could be calculated. Model confidence %69.
Components: P/B target: 13.47 | EV/EBITDA target: 39.83 | DCF target: 73.65
Damodaran Valuation
-
Moderate Damodaran score (55/100). ROIC (%5.3) – WACC (%10.2) difference -4.9 bps. Value creation capacity limited.
Moderate
Dalio Risk Analysis
-
Moderate debt risk (68/100). Interest coverage ratio 6.4x — strong. Debt/EBITDA 3.4x — manageable.
Leverage: 56/100 | Debt Service: 91/100 | Quality: 59/100
ROIC - Return on Capital
%5.3
ROIC (%5.3) cost of capital (10.2%) below → destroying value.
WACC: %10.2
DCF Discounted Cash Flow
116.45
DCF modeli 116.45 target value produced — compared to current price %374.4 undervalued.
Current price: 24.55
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
—
Graham Intrinsic Value
$11.3
Expensive
⚖️ Sector Comparison
P/B Ratio
6.36x vs 3.47x
Compared to sector %83 more expensive (by book value)
EV/EBITDA
11.9x vs 19.3x
Compared to sector %38 lower EV/EBITDA
ROIC vs WACC
%5.3 vs %10.2 WACC
ROIC 4.9 bps below cost of capital
Net Profit Margin (TTM)
%6.1 vs %10.7 EBITDA margin
TTM net profit margin %6.1
↔
TRAMA-99 Trend — Near TRAMA
Price (24.55), TRAMA-99 line (24.55) at close levels (%+0.0). Important decision zone — breakout direction will determine the trend.
Price:: 24.55
TRAMA: 24.55
Difference: %+0.0
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
▲ içeriden alım · ▼ içeriden satım · ★ katalizör (haber-sezgisel) · ■ 13D aktivist · ■ 13G pasif — SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
RSI (14) ?
Bollinger Bands ?
MACD ?
Kurumsal Holdings — 13F (çeyreklik) ?

İçeriden Alım-Satım Akışı

Kim aldı, kim sattı, ne kadar

LCLN — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.